Barratt Ruth, Clendon Grace, Gibson Barbara, Roberts Sally A
Specialist, Infection Prevention & Control, Health Quality & Safety Commission, Christchurch, New Zealand.
Analyst/Data Scientist, Health Quality & Safety Commission, Wellington, New Zealand.
N Z Med J. 2022 Oct 7;135(1563):29-35. doi: 10.26635/6965.5811.
The primary aim of this study was to identify the source of healthcare-associated Staphylococcus aureus bacteraemia (HA-SAB) in acute district health board (DHB) hospitals to inform future national quality improvement activities.
De-identified HA-SAB event source information was submitted to the Commission from all DHBs for the period 1 January 2017 to 30 June 2021. Data was categorised and analysed to identify trends and significant sources of infection.
There were 1,867 HA-SAB events. Of the events where S. aureus susceptibility results were reported, 159 (10%) isolates were methicillin-resistant S. aureus. The principal sources of HA-SAB were medical devices (65%), surgical site infection (10%), and organ site (8%). Ninety-five percent of medical devices were for vascular access, primarily central venous catheters (50%) and peripheral intravenous catheters (45%).
This study has identified intravascular devices as significant sources of HA-SAB. Ongoing surveillance for HA-SAB source is required to identify the major risk factors and to support quality improvement activities targeting infection prevention measures and best practice related to intravascular and other medical devices.
本研究的主要目的是确定急性地区卫生委员会(DHB)医院中与医疗保健相关的金黄色葡萄球菌菌血症(HA-SAB)的来源,以为未来的全国质量改进活动提供信息。
2017年1月1日至2021年6月30日期间,所有DHB将去识别化的HA-SAB事件源信息提交给委员会。对数据进行分类和分析,以确定感染趋势和重要来源。
共发生1867起HA-SAB事件。在报告了金黄色葡萄球菌药敏结果的事件中,159株(10%)分离株为耐甲氧西林金黄色葡萄球菌。HA-SAB的主要来源是医疗器械(65%)、手术部位感染(10%)和器官部位(8%)。95%的医疗器械用于血管通路,主要是中心静脉导管(50%)和外周静脉导管(45%)。
本研究已确定血管内装置是HA-SAB的重要来源。需要持续监测HA-SAB的来源,以确定主要风险因素,并支持针对感染预防措施以及与血管内和其他医疗器械相关的最佳实践的质量改进活动。